"This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public."
This is HCP only content
QuiremSpheres® is based on Holmium-166 microspheres, which were developed in the clinic as an alternative to Yttrium-90 microspheres for treating unresectable liver tumors with selective internal radiation therapy (SIRT). Holmium-166 microspheres can be imaged with SPECT and MR, with high sensitivity and resolution, respectively. QuiremScout™ is a clinically safe and more predictive alternative to the currently used Tech-99m-MAA. This supports clinics by aiming to improve the evaluation of lung shunting and the estimation of intrahepatic and extrahepatic biodistribution of microspheres. Q-Suite™ allows you to perform accurate post-treatment dosimetry of Holmium-166 SIRT. With Q-Suite™, you can evaluate dose absorption at a voxel level based on SPECT/CT or MR imaging and generate a comprehensive dosimetry report per patient.
Find out more about our wide choice of Terumo products that can support you in the treatment of HCC and mCRC with SIRT
Smiths et. Al.
Prof. dr. M.G.E.H Lam (NM), Dr. R.C.G. Bruijnen (IR), M.T.M. Reinders-Hut
A 73-years old female patient diagnosed with hepatocellular carcinoma (HCC) with liver only disease was treated with holmium-166 (166Ho) SIRT. Patient presented with…
Prof. Dr. Ralf-Thorsten Hoffmann (IR) and Dr. Klaus Zoephel (NM)
A 64-year-old male patient with a history of metastatic colorectal cancer
(mCRC) was diagnosed two years earlier and subsequently treated by
resection of liver segments II and III and atypical...
A 77-year-old male patient with a history of hepatocellular carcinoma
(HCC) was first diagnosed with large HCC in the right liver lobe (LL)
without cirrhosis, and treated by embolization of...
Giuseppe Boni, MD; Irene Bargellini, MD; Elena Bozzi, MD; Rosa Cervelli, MD; Claudio Antonio
A 47-years old female patient diagnosed with left colon adenoCa (kRAS
mut codon 13, BRAF wt, NRAS wt, MSS) and synchronous hepatic
metastasis three years before, treated with multiple...
Irene Bargellini, MD; Giuseppe Boni, MD; Elena Bozzi, MD; Rosa Cervelli, MD; Claudio Antonio
A 61-years old male patient diagnosed with right colon
adenoCa three years before (G2, pT3N2, KRAS mut) and liver
metastasis one year later...
Giulio Eugenio Vallati,MD
A 67-years-old man with no history of liver disease presented with
4 months of abdominal pain and weight loss. Abdominal CT showed a
large hepatic lesion in the left lobe (74 x 57 x 46 mm) with portal vein
Giulio Eugenio Vallati, MD
An 80-years-old man with history of cirrhosis (HCV+) affected by progressive weight loss and high AFP level. Abdominal CT showed a massive hepatic lesion in the right lobe (140 x 110 x 75 mm) with right portal vein invasion...
As part of Terumo’s continuing commitment to Interventional Oncology and physician educational program, we are running Liver focused workshops to give physicians the opportunity to have a practical experience with the technological and procedural choices that the Terumo IO toolkit can provide in the treatment of Liver Cancer.
Workshop location: UMC Utrecht | Utrecht, NL
Looking for products related information, partnership opportunities, or simply keeping updated on Terumo’s news. Don’t hesitate to subscribe.
Please simply fill in the following information
Send me updates & news about Terumo.
* Mandatory fields